Opportunity Information: Apply for CDC RFA PS10 1090
Apply for CDC RFA PS10 1090
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Support for the Ministry of Healths Monitoring and Evaluation System, Surveillance, Blood Safety and Laboratory Infrastructure in the Republic of the Ukraine under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Apr 19, 2010 and posted on Jan 27, 2010.
- Applicants must submit their applications by May 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- National Committee on AIDS/TB and Other Socially Dangerous Diseases 7 Grushevskogo Street Kyiv 01021 Ukraine
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity (CDC RFA PS10-1090) is a CDC discretionary funding announcement under PEPFAR that was set up to support Ukraine in strengthening key public health systems used to control and monitor HIV/AIDS. The funding mechanism is a cooperative agreement, which typically means CDC expects to stay actively involved with the recipient through technical guidance, collaboration on work planning, and ongoing oversight rather than simply issuing funds and stepping back. The overall purpose is to improve the Ministry of Healths ability to respond to the HIV epidemic by building stronger national systems in four linked areas: monitoring and evaluation (M and E), surveillance, blood safety, and laboratory infrastructure.
In practical terms, the opportunity focuses on improving how Ukraine collects, manages, analyzes, and uses HIV-related data for decision-making. Strengthening an M and E system generally involves standardizing indicators, improving data flow from service delivery sites up to national levels, building data quality assurance processes, training staff to interpret results, and ensuring that the information produced is actually used to guide policy and program improvements. Alongside M and E, the announcement emphasizes surveillance, which usually refers to organized systems for tracking HIV trends, risk patterns, and the epidemiology of the epidemic over time. That can include improving routine case reporting, sentinel surveillance, behavioral surveillance, and integrating surveillance findings into planning for prevention and treatment services.
A major pillar of the announcement is support for the National Blood Transfusion Services, with the aim of protecting the blood supply and reducing transmission risks through transfusion. Work in this area often includes strengthening policies and oversight for donor screening, improving quality management systems, ensuring consistent testing algorithms, upgrading procedures for collection and storage, and reinforcing training and supervision across blood service facilities. The blood safety component is closely connected to laboratory capacity, since accurate screening depends on reliable lab infrastructure, quality control, and standardized protocols.
The laboratory infrastructure strengthening element is intended to improve the overall capability and reliability of the public health laboratory network supporting HIV programs and related services. This commonly involves investments in equipment, maintenance systems, procurement and supply chain practices for reagents and consumables, quality assurance and external quality assessment participation, biosafety improvements, standard operating procedures, and workforce development for lab personnel. By improving laboratory systems, the Ministry of Health can better support HIV testing, confirmatory diagnostics, and monitoring functions that underpin both prevention and treatment efforts.
Funding details indicate that approximately 3,000,000 USD was expected to be available in fiscal year 2010 to support a single award, while the estimated total funding amount listed is 15,000,000 USD, suggesting the possibility of a multi-year cooperative agreement with funding allocated across budget periods depending on performance, availability of funds, and program priorities. There was no cost sharing or matching requirement. The program is tied to CFDA 93.067 (Global AIDS), reflecting its alignment with PEPFAR and broader US government global HIV/AIDS objectives.
Eligibility in the posted data points specifically to the National Committee on AIDS/TB and Other Socially Dangerous Diseases in Kyiv, Ukraine, indicating that this opportunity was highly targeted rather than broadly competed among many types of applicants. Administrative details show the announcement was posted on January 27, 2010, with an original closing date of March 30, 2010 that was later extended to May 17, 2010, and it was archived on June 14, 2010. The sponsoring agency is the Centers for Disease Control and Prevention, and the contact provided for access issues was the CDC Procurement and Grants Office TIMS line.
Frequently Asked Questions (FAQs) - CDC RFA PS10-1090 (Ukraine HIV Systems Strengthening)
What is CDC RFA PS10-1090?
CDC RFA PS10-1090 is a CDC discretionary funding announcement under PEPFAR designed to support Ukraine in strengthening key public health systems used to control and monitor HIV/AIDS.
What is the overall purpose of this grant opportunity?
The purpose is to improve the Ministry of Health's ability to respond to the HIV epidemic by building stronger national systems in four linked areas: monitoring and evaluation (M and E), surveillance, blood safety, and laboratory infrastructure.
What type of funding mechanism is used?
The opportunity uses a cooperative agreement. This typically means CDC expects to remain actively involved with the recipient through technical guidance, collaboration on work planning, and ongoing oversight.
How is a cooperative agreement different from a typical grant?
Based on the description provided, CDC does not simply issue funds and step back. Instead, CDC is expected to stay engaged with the recipient through technical input, collaborative planning, and oversight during implementation.
Which public health system areas does the grant focus on?
The announcement focuses on strengthening national systems for: (1) monitoring and evaluation (M and E), (2) surveillance, (3) blood safety through National Blood Transfusion Services, and (4) laboratory infrastructure.
What does "monitoring and evaluation (M and E)" mean in this announcement?
In practical terms, M and E strengthening focuses on improving how HIV-related data are collected, managed, analyzed, and used for decision-making. The description highlights activities such as standardizing indicators, improving data flow from service sites to national levels, building data quality assurance processes, training staff to interpret results, and ensuring data are used to guide policy and program improvements.
What does the opportunity emphasize about HIV surveillance?
The announcement emphasizes strengthening organized systems for tracking HIV trends, risk patterns, and the epidemiology of the epidemic over time. Examples mentioned include improving routine case reporting, sentinel surveillance, behavioral surveillance, and integrating surveillance findings into planning for prevention and treatment services.
What is the blood safety component intended to support?
A major pillar is support for the National Blood Transfusion Services, with the goal of protecting the blood supply and reducing HIV transmission risks through transfusion.
What kinds of activities are typically included under blood safety in this announcement?
The description points to work such as strengthening policies and oversight for donor screening, improving quality management systems, ensuring consistent testing algorithms, upgrading collection and storage procedures, and reinforcing training and supervision across blood service facilities.
How is blood safety connected to laboratory strengthening in this opportunity?
The announcement describes blood safety as closely connected to laboratory capacity because accurate screening depends on reliable laboratory infrastructure, quality control, and standardized protocols.
What does "laboratory infrastructure strengthening" mean here?
Laboratory infrastructure strengthening is intended to improve the capability and reliability of the public health laboratory network supporting HIV programs and related services. The description notes common elements such as equipment, maintenance systems, procurement and supply chain practices for reagents and consumables, quality assurance and external quality assessment participation, biosafety improvements, standard operating procedures, and workforce development for laboratory personnel.
What kinds of HIV program functions can improved laboratories support?
As described, strengthened laboratory systems can better support HIV testing, confirmatory diagnostics, and monitoring functions that underpin both prevention and treatment efforts.
How much funding was expected to be available?
The funding details indicate approximately USD 3,000,000 was expected to be available in fiscal year 2010 to support a single award.
What does the estimated total funding amount of USD 15,000,000 mean?
The listed total estimated funding amount of USD 15,000,000 suggests the cooperative agreement may have been multi-year, with funding allocated across budget periods depending on performance, availability of funds, and program priorities.
How many awards were expected?
The announcement indicates funding was expected to support a single award.
Was cost sharing or matching required?
No cost sharing or matching requirement was indicated.
What CFDA program is this opportunity associated with?
The opportunity is tied to CFDA 93.067 (Global AIDS), reflecting alignment with PEPFAR and broader US government global HIV/AIDS objectives.
Who was eligible to apply, based on the posted information?
The eligibility information specifically points to the National Committee on AIDS/TB and Other Socially Dangerous Diseases in Kyiv, Ukraine, indicating the opportunity was highly targeted rather than broadly competed.
When was the opportunity posted?
The announcement was posted on January 27, 2010.
What was the closing date, and was it extended?
The original closing date was March 30, 2010, and it was later extended to May 17, 2010.
When was the opportunity archived?
The announcement was archived on June 14, 2010.
Which agency sponsored this funding announcement?
The sponsoring agency is the Centers for Disease Control and Prevention (CDC).
Who was listed as the contact for access issues?
The contact listed for access issues was the CDC Procurement and Grants Office TIMS line.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: DoD Bone Marrow Failure Exploration Hypothesis Development Award
Previous opportunity: SMART FY2010 Comprehensive Approaches to Sex Offender Management Training and Technical Assistance Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS10 1090
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS10 1090) also looked into and applied for these:
| Funding Opportunity |
|---|
| Providing HIV Prevention, Treatment, and Care Services to Injecting Drug users, Incarcerated Population, and other Vulnerable Populations in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan under PEPFAR Apply for CDC RFA PS10 10156 Funding Number: CDC RFA PS10 10156 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| NEI Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grants (T32) for Statistical Genetics and Genome Informatics Apply for RFA EY 10 001 Funding Number: RFA EY 10 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building the Capacity of Regional Health Management Team to Coordinate, Manage, and Support HIV/AIDS Clinical Services in the United Republic of Tanzania under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10127 Funding Number: CDC RFA PS10 10127 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Improving Access to and Delivery of HIV/AIDS Services by Strengthening Community and Health Center Linkages in the Eastern Province of the Republic of Zambia Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10108 Funding Number: CDC RFA PS10 10108 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Strengthening Health Information Systems Implementation, Capacity, and Infrastructure in the Republic of Mozambique Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1086 Funding Number: CDC RFA PS10 1086 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Pediatric Pulmonary Centers (PPC) Apply for HRSA 10 103 Funding Number: HRSA 10 103 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| HIV Prevention for Most at Risk Populations (MARPs), Republic of Mozambique, Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1085 Funding Number: CDC RFA PS10 1085 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,946,000 |
| Strengthening the Blood Transfusion Services in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1079 Funding Number: CDC RFA PS10 1079 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Prevention of Suicidal Behavior through the Enhancement of Connectedness (U01) Apply for RFA CE 10 006 Funding Number: RFA CE 10 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Impact of Japanese Encephalitis Vaccination in Cambodia (U01) Apply for RFA CK 10 003 Funding Number: RFA CK 10 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R03) Apply for PA 10 104 Funding Number: PA 10 104 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing and Improving HIV/AIDS Clinical Nursing Capacities and Institutional Structural Support in India Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10139 Funding Number: CDC RFA PS10 10139 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| AIDS Education and Training National Resource Center Apply for HRSA 10 131 Funding Number: HRSA 10 131 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Capacity Building to Develop Standard Electronic Client Information Data Systems Apply for HRSA 10 082 Funding Number: HRSA 10 082 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening Local Government Response to Vulnerable Children (SLGRVC) Apply for RFA 617 10 000004 Funding Number: RFA 617 10 000004 Agency: Uganda USAID Kampala Category: Health Funding Amount: $20,000,000 |
| Research on Alcohol and HIV/AIDS (R01) Apply for PA 10 103 Funding Number: PA 10 103 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research on Alcohol and HIV/AIDS (R21) Apply for PA 10 105 Funding Number: PA 10 105 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Knowledge Synthesis Center for Evaluating Genomic Application in Practice and Prevention (U18) Apply for RFA GD10 001 Funding Number: RFA GD10 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Centers of Research Translation (P50) Apply for RFA AR 11 002 Funding Number: RFA AR 11 002 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| National Environmental Public Health Tracking Program National Association for Health Data Organizations Apply for CDC RFA EH10 1003 Funding Number: CDC RFA EH10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS10 1090", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.